Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

FTSE flirts with 14-year high as housebuilders provide boost

FTSE flirts with 14-year high as housebuilders provide boost

The FTSE 100 has touched a 14-year high in a day of chopping trading where housebuilders have led momentum, supported by AstraZeneca as US rival Pfizer hinted it could bid more for the pharmaceutical giant.

The FTSE 100 briefly reached 6,877 this morning, the highest level in more than 14 years, but has since lost ground. The UK blue-chip index is now up 12 points, or 0.2% on the day, at 6,864. With dividends included, the FTSE is up around 3% since the start of the year, having recovered from falls in February and April.

Barratt Developments (BDEV), led the index higher, up 2.9% to 385p, followed by Persimmon (PSN), up 2.6% at £13.95, after smaller rival Taylor Wimpey (TW) soared 5.7% on good results.

Engineers and component manufacturers also gained with Melrose Industries (MRON), GKN (GKN) and Rolls-Royce (RR) dominating the leaders' list.

AstraZeneca (AZN) gained 88.5p or 1.9% to £46.99 as Pfizer hinted it could raise its £50 per share offer for the British drugs company. Pfizer chief executive Ian Read this morning laid out the case for its takeover of Astra before MPs. Speaking before the House of Commons business committee, Read said the proposed takeover was was an opportunity 'to bring the strength of the combined portfolios and to bring our financial strength into the Uk and globally'.  

EasyJet (EZJ) dived 4.6% to £16.51 despite cutting pre-tax losses by 13% to £53 million in the six months to 31 March. The first half of the year is a period in which the budget airline normally runs a loss. It said a ‘ruthless focus on cost’ meant it was well placed for the second half of the year.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter